scispace - formally typeset
Journal ArticleDOI

Immunological biomarkers of tuberculosis.

Reads0
Chats0
TLDR
Interplay between the host immune system and M. tuberculosis may provide a platform for the identification of suitable biomarkers, through both unbiased and targeted hypothesis-driven approaches.
Abstract
Currently there are no sufficiently validated biomarkers to aid the evaluation of new tuberculosis vaccine candidates, the improvement of tuberculosis diagnostics or the development of more effective and shorter treatment regimens. To date, the detection of Mycobacterium tuberculosis or its products has not been able to adequately address these needs. Understanding the interplay between the host immune system and M. tuberculosis may provide a platform for the identification of suitable biomarkers, through both unbiased and targeted hypothesis-driven approaches. Here, we review immunological markers, their relation to M. tuberculosis infection stages and their potential use in the fight against tuberculosis.

read more

Citations
More filters
Journal ArticleDOI

The Immune Response in Tuberculosis

TL;DR: What the authors know about the immune response in tuberculosis, in human disease, and in a range of experimental models is summarized, all of which are essential to advancing the mechanistic knowledge base of the host-pathogen interactions that influence disease outcome.
Journal ArticleDOI

Advances in the development of new tuberculosis drugs and treatment regimens

TL;DR: Current concepts and recent advances in TB drug discovery and development are covered, including an update of ongoing TB treatment trials, newer clinical trial designs, TB biomarkers and adjunct host-directed therapies.
Journal ArticleDOI

The immunological life cycle of tuberculosis.

TL;DR: It is proposed that there are distinct stages in the immune response to M. tuberculosis that form an 'immunological life cycle' and this thesis will provide a framework for investigation to understand immunity toM.
Journal ArticleDOI

Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing

TL;DR: This work uses individually marked Mtb isolates and quantitative measures of culturable and cumulative bacterial burden to show that most lung lesions are probably founded by a single bacterium and reach similar maximum burdens, and suggests that lesional heterogeneity arises through differential killing of bacteria after the onset of adaptive immunity.
References
More filters
Journal ArticleDOI

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.

TL;DR: The prevention of HIV and TB, the extension of WHO DOTS programs, and a focused effort to control HIV-related TB in areas of high HIV prevalence are matters of great urgency.
Journal ArticleDOI

Physiological and pathological roles for microRNAs in the immune system

TL;DR: Recent advances in understanding of both the intended functions of miRNAs in managing immune cell biology and their pathological roles when their expression is dysregulated are discussed.
Journal ArticleDOI

IL-23 and IL-17 in the establishment of protective pulmonary CD4 + T cell responses after vaccination and during Mycobacterium tuberculosis challenge

TL;DR: It is proposed that vaccination induces IL-17-producing CD4+ T cells that populate the lung and, after challenge, trigger the production of chemokines that recruit CD4- T cells producing interferon-γ, which ultimately restrict bacterial growth.
Related Papers (5)